Bladder cancer--genetic overview
- PMID: 11208514
Bladder cancer--genetic overview
Abstract
Background: This article review the serial genetic changes which are responsible to the initiation and progression of bladder cancer. Knowledge of the exact genetic alteration has a direct implication on the development of knew more sensitive and specific tool for an early diagnosis and better prognosis calculations.
Conclusion: Bladder cancer develop and progress through a series of genetic alterations. Understanding of the genetic mechanisms which lead to malignant transformation gave rise to the development of various genetic mechanisms which lead to malignant transformation gave rise to the development of various genetic tools providing better ability of early detection and more accurate prognosis prediction.
Similar articles
-
Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer.Oncogene. 1999 Feb 4;18(5):1185-96. doi: 10.1038/sj.onc.1202385. Oncogene. 1999. PMID: 10022124
-
Genetic alterations associated with bladder cancer.Important Adv Oncol. 1994:71-83. Important Adv Oncol. 1994. PMID: 7911446 Review. No abstract available.
-
[Non-invasive molecular detection of bladder cancer].Harefuah. 2009 Jan;148(1):66-9, 86. Harefuah. 2009. PMID: 19320394 Hebrew.
-
Tumor suppressor gene alterations in bladder carcinoma. Translational correlates to clinical practice.Surg Oncol Clin N Am. 1995 Apr;4(2):231-40. Surg Oncol Clin N Am. 1995. PMID: 7796283 Review.
-
Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.Nat Clin Pract Urol. 2006 Dec;3(12):642-52. doi: 10.1038/ncpuro0649. Nat Clin Pract Urol. 2006. PMID: 17149381 Review.
Cited by
-
Germline HOXB13 mutation p.G84E do not confer an increased bladder or kidney cancer risk in polish population.Hered Cancer Clin Pract. 2022 Jan 4;20(1):1. doi: 10.1186/s13053-021-00208-8. Hered Cancer Clin Pract. 2022. PMID: 34983599 Free PMC article.
-
The Clinical Relevance of Fragile Histidine Triad Protein (FHIT) in Patients with Bladder Cancer.Med Sci Monit. 2018 May 12;24:3113-3118. doi: 10.12659/MSM.906721. Med Sci Monit. 2018. PMID: 29752880 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical